Literature DB >> 17494756

Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.

Ling Weng1, Julian Dyson, Francesco Dazzi.   

Abstract

Low- or reduced-intensity conditioning regimens for allogeneic hemopoietic stem cell transplantation are effective at establishing donor hematopoietic engraftment and host-vs.-graft (HvG) tolerance. We investigated the mechanisms of HvG tolerance induction and maintenance in an animal model in which transplantation of sublethally irradiated female recipients with bone marrow (BM) from syngeneic male donors produces mixed chimerism. Splenocytes from chimeric mice inhibited HY-specific CD8(+) T cell responses both in vitro and in vivo, and their adoptive transfer facilitated donor hematopoietic engraftment. These properties were contained within the CD4(+)CD25(+) population. The conditioning protocol alone led to a proportional expansion of regulatory T cells (T(regs)), but the inhibitory activity was induced only if male BM was infused. The administration of anti-CD25-depleting antibodies to conditioned recipients at time of BM transplantation prevented donor-recipient chimerism but did not affect engraftment if performed after the establishment of chimerism, thus indicating that recipient T(regs) are required for the generation but not the maintenance of HvG tolerance. We conclude that donor-specific T(regs) of recipient origin are recruited when the donor antigens are present during reduced-intensity conditioning-induced T(reg) expansion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494756      PMCID: PMC1895964          DOI: 10.1073/pnas.0701031104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

2.  Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.

Authors:  Olivier Joffre; Nathalie Gorsse; Paola Romagnoli; Denis Hudrisier; Joost P M van Meerwijk
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

Review 3.  Mixed hematopoietic chimerism and transplantation tolerance.

Authors:  B Nikolic; M Sykes
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Authors:  S Onizuka; I Tawara; J Shimizu; S Sakaguchi; T Fujita; E Nakayama
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

5.  Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning.

Authors:  M Sykes; G L Szot; K A Swenson; D A Pearson
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

6.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

Review 7.  Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

Authors:  F Dazzi; R M Szydlo; J M Goldman
Journal:  Exp Hematol       Date:  1999-10       Impact factor: 3.084

8.  Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.

Authors:  T C Pearson; J C Madsen; C P Larsen; P J Morris; K J Wood
Journal:  Transplantation       Date:  1992-09       Impact factor: 4.939

9.  Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells.

Authors:  R Scully; S Qin; S Cobbold; H Waldmann
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

10.  Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells.

Authors:  M V Doyle; E Parks; W O Weigle
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  3 in total

1.  Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.

Authors:  Allison L Bayer; Jackeline Chirinos; Cecilia Cabello; Jing Yang; Takaji Matsutani; Thomas R Malek; Robert B Levy
Journal:  Eur J Immunol       Date:  2011-10-31       Impact factor: 5.532

2.  CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo.

Authors:  Yiming Huang; Larry D Bozulic; Thomas Miller; Hong Xu; Lala-Rukh Hussain; Suzanne T Ildstad
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

3.  Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.

Authors:  Larry D Bozulic; Yujie Wen; Hong Xu; Suzanne T Ildstad
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.